PROSPECTIVE GENETICALLY RANDOMIZED COMPARISON BETWEEN INTENSIVE POSTINDUCTION CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN ADULTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA

被引:43
作者
ARCHIMBAUD, E [1 ]
THOMAS, X [1 ]
MICHALLET, M [1 ]
JAUBERT, J [1 ]
TRONCY, J [1 ]
GUYOTAT, D [1 ]
FIERE, D [1 ]
机构
[1] HOP NORD ST PRIEST JAREZ,ST PRIEST JAREZ,FRANCE
关键词
D O I
10.1200/JCO.1994.12.2.262
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare intensive chemotherapy and HLA-identical allogeneic bone marrow transplantation (BMT) as postinduction therapy in young adults with acute myeloid leukemia (AML). Patients and Methods: Seventy-eight consecutive AML patients younger than 40 years of age were treated according to a prospective protocol in which every patient in complete remission (CR) with an HLA-identical sibling was scheduled to receive BMT rather than intensive chemotherapy consolidation. To minimize comparison biases, the availability or not of an HLA-identical sibling donor was considered to be the equivalent of genetic randomization to the BMT or chemotherapy arm, respectively. Results: Fifty-eight patients (74%) achieved a CR. A donor was found for 27 patients (BMT arm), and 20 of these patients were actually transplanted in first CR. The 31 patients without a donor were allocated to the chemotherapy arm. Patients in the two arms had similar disease characteristics at diagnosis and previous responses to induction therapy. The cumulative risk of relapse was 43% ± 24% in the BMT arm and 67% ± 19% in the chemotherapy arm (P = .1). The 7-year leukemia-free survival (LFS) rate was 41% ± 20% in the BMT arm and 27% ± 16% in the chemotherapy arm, a difference that is not statistically significant between the two arms. The overall survival rates were 41% ± 20% and 46% ± 19%, respectively. Conclusion: In this study, the availability of an HLA-identical sibling donor was not associated with a better survival rate because of both the impossibility of some patients with a donor to receive BMT and the more efficient salvage treatment of patients who relapsed after intensive consolidation chemotherapy than of patients who relapsed after BMT.
引用
收藏
页码:262 / 267
页数:6
相关论文
共 22 条
[1]   PROSPECTIVE COMPARATIVE-STUDY OF BONE-MARROW TRANSPLANTATION AND POSTREMISSION CHEMOTHERAPY FOR CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA [J].
AMADORI, S ;
TESTI, AM ;
ARICO, M ;
COMELLI, A ;
GIULIANO, M ;
MADON, E ;
MASERA, G ;
RONDELLI, R ;
ZANESCO, L ;
MANDELLI, F .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1046-1054
[2]  
APPELBAUM FR, 1988, BLOOD, V72, P179
[3]  
ARCHIMBAUD E, 1991, BLOOD, V77, P1894
[4]  
BENNETT JM, 1985, ANN INTERN MED, V103, P626
[5]  
BLAISE D, 1992, BLOOD, V79, P2578
[6]  
CHAMPLIN R, 1987, BLOOD, V69, P1551
[7]   TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE CONTROLLED TRIAL OF BONE-MARROW TRANSPLANTATION VERSUS CONSOLIDATION CHEMOTHERAPY [J].
CHAMPLIN, RE ;
HO, WG ;
GALE, RP ;
WINSTON, D ;
SELCH, M ;
MITSUYASU, R ;
LENARSKY, C ;
ELASHOFF, R ;
ZIGHELBOIM, J ;
FEIG, SA .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :285-291
[8]   ALLOGENEIC BONE-MARROW TRANSPLANTATION VERSUS INTENSIFICATION CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN 1ST REMISSION - A PROSPECTIVE CONTROLLED TRIAL [J].
CONDE, E ;
IRIONDO, A ;
RAYON, C ;
RICHARD, C ;
FANJUL, E ;
GARIJO, J ;
HERMOSA, V ;
COMA, A ;
BELLO, C ;
CARRERA, D ;
BARO, J ;
ZUBIZARRETA, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 68 (02) :219-226
[9]   ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A PROGRAM OF INTENSIVE SEQUENTIAL CHEMOTHERAPY FOR CHILDREN AND YOUNG-ADULTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION [J].
DAHL, GV ;
KALWINSKY, DK ;
MIRRO, J ;
LOOK, AT ;
PUI, CH ;
MURPHY, SB ;
MASON, C ;
RUGGIERO, M ;
SCHELL, M ;
JOHNSON, FL ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) :295-303
[10]   ARABINOSYL CYTOSINE - A USEFUL AGENT IN TREATMENT OF ACUTE LEUKEMIA IN ADULTS [J].
ELLISON, RR ;
HOLLAND, JF ;
WEIL, M ;
JACQUILLAT, C ;
BOIRON, M ;
BERNARD, J ;
SAWITSKY, A ;
ROSNER, F ;
GUSSOFF, B ;
SILVER, RT ;
KARANAS, A ;
CUTTNER, J ;
SPURR, CL ;
HAYES, DM ;
BLOM, J ;
LEONE, LA ;
HAURANI, F ;
KYLE, R ;
HUTCHISON, JL ;
FORCIER, RJ ;
MOON, JH .
BLOOD, 1968, 32 (04) :507-+